Work

Impact of Dosage Modifications on Efficacy: Insights from Select Tyrosine Kinase Inhibitors Approved for Treatment of Non-Small Cell Lung Cancer with EGFR Mutations

Year: 2026

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-26-1022

Authors: Santiago D. Carrasquilla, Youwei Bi, Wenjuan Gu, Amal Ayyoub, Elimika Pfuma Fletcher, Jiang Liu, Anuradha Ramamoorthy, Yuan-Li Shen, Stacy S. Shord, Issam Zineh, Rajanikanth Madabushi

Institution: United States Food and Drug Administration

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7225431732

FWCI:

Cites:

Cited by:

Related to: 10